Cargando…
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]”
Autores principales: | Krolewiecki, Alejandro, Lifschitz, Adrián, Moragas, Matías, Travacio, Marina, Valentini, Ricardo, Alonso, Daniel F., Solari, Rubén, Tinelli, Marcelo A., Cimino, Rubén O., Álvarez, Luis, Fleitas, Pedro E., Ceballos, Laura, Golemba, Marcelo, Fernández, Florencia, de Oliveira, Diego Fernández, Astudillo, German, Baeck, Inés, Farina, Javier, Cardama, Georgina A., Mangano, Andrea, Spitzer, Eduardo, Gold, Silvia, Lanusse, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387727/ https://www.ncbi.nlm.nih.gov/pubmed/34462733 http://dx.doi.org/10.1016/j.eclinm.2021.101119 |
Ejemplares similares
-
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
por: Krolewiecki, Alejandro, et al.
Publicado: (2021) -
Godspeed, EClinicalMedicine
Publicado: (2018) -
Response to the letter by Prof Jonathan Deeks to the Lancet EClinicalMedicine editor
por: Leber, Werner, et al.
Publicado: (2021) -
Retraction notice to “The growth mindset in medical education: A call
for faculty development” [EClinicalMedicine 29–30 (2020)
100648]
por: Campbell, Jason, et al.
Publicado: (2021) -
Mapping the global distribution of Strongyloides stercoralis and hookworms by ecological niche modeling
por: Fleitas, Pedro Emanuel, et al.
Publicado: (2022)